TMPRSS2 is a functional receptor for human coronavirus HKU1

Archive ouverte

Saunders, Nell | Fernandez, Ignacio | Planchais, Cyril | Michel, Vincent | Rajah, Maaran Michael | Baquero Salazar, Eduard | Postal, Jeanne | Porrot, Francoise | Guivel-Benhassine, Florence | Blanc, Catherine | Chauveau-Le Friec, Gaëlle | Martin, Augustin | Grzelak, Ludivine | Oktavia, Rischa Maya | Meola, Annalisa | Ahouzi, Olivia | Hoover-Watson, Hunter | Prot, Matthieu | Delaune, Deborah | Cornelissen, Marion | Deijs, Martin | Meriaux, Véronique | Mouquet, Hugo | Simon-Lorière, Etienne | van der Hoek, Lia | Lafaye, Pierre | Rey, Felix | Buchrieser, Julian | Schwartz, Olivier

Edité par CCSD ; Nature Publishing Group -

International audience. Four endemic seasonal human coronaviruses causing common colds circulate worldwide: HKU1, 229E, NL63 and OC43 (ref. 1). After binding to cellular receptors, coronavirus spike proteins are primed for fusion by transmembrane serine protease 2 (TMPRSS2) or endosomal cathepsins2,3,4,5,6,7,8,9. NL63 uses angiotensin-converting enzyme 2 as a receptor10, whereas 229E uses human aminopeptidase-N11. HKU1 and OC43 spikes bind cells through 9-O-acetylated sialic acid, but their protein receptors remain unknown12. Here we show that TMPRSS2 is a functional receptor for HKU1. TMPRSS2 triggers HKU1 spike-mediated cell–cell fusion and pseudovirus infection. Catalytically inactive TMPRSS2 mutants do not cleave HKU1 spike but allow pseudovirus infection. Furthermore, TMPRSS2 binds with high affinity to the HKU1 receptor binding domain (Kd 334 and 137 nM for HKU1A and HKU1B genotypes) but not to SARS-CoV-2. Conserved amino acids in the HKU1 receptor binding domain are essential for binding to TMPRSS2 and pseudovirus infection. Newly designed anti-TMPRSS2 nanobodies potently inhibit HKU1 spike attachment to TMPRSS2, fusion and pseudovirus infection. The nanobodies also reduce infection of primary human bronchial cells by an authentic HKU1 virus. Our findings illustrate the various evolution strategies of coronaviruses, which use TMPRSS2 to either directly bind to target cells or prime their spike for membrane fusion and entry.

Suggestions

Du même auteur

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Archive ouverte | Planas, Delphine | CCSD

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants were first identified in the United Kingdom and South Africa, respectively, and have since spread to ...

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

Archive ouverte | Saunders, Nell | CCSD

International audience. Background: SARS-CoV-2 lineages are continuously evolving. As of December 2021, the AY.4.2 Delta sub-lineage represented 20 % of sequenced strains in the UK and had been detected in dozens of...

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

Archive ouverte | Rajah, Maaran Michael | CCSD

International audience. Severe COVID-19 is characterized by lung abnormalities, including the presence of syncytial pneumocytes. Syncytia form when SARS-CoV-2 spike protein expressed on the surface of infected cells...

Chargement des enrichissements...